Neurology Partnership Limited - Accounts to registrar (filleted) - small 18.2

Neurology Partnership Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v18.3.0.592 SC209236 Board of Directors 1.4.17 31.3.18 31.3.18 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureSC2092362017-03-31SC2092362018-03-31SC2092362017-04-012018-03-31SC2092362016-03-31SC2092362016-04-012017-03-31SC2092362017-03-31SC209236ns15:Scotland2017-04-012018-03-31SC209236ns14:PoundSterling2017-04-012018-03-31SC209236ns10:Director12017-04-012018-03-31SC209236ns10:PrivateLimitedCompanyLtd2017-04-012018-03-31SC209236ns10:SmallEntities2017-04-012018-03-31SC209236ns10:AuditExempt-NoAccountantsReport2017-04-012018-03-31SC209236ns10:SmallCompaniesRegimeForDirectorsReport2017-04-012018-03-31SC209236ns10:SmallCompaniesRegimeForAccounts2017-04-012018-03-31SC209236ns10:AbridgedAccounts2017-04-012018-03-31SC209236ns10:Director22017-04-012018-03-31SC209236ns10:RegisteredOffice2017-04-012018-03-31SC209236ns5:CurrentFinancialInstruments2018-03-31SC209236ns5:CurrentFinancialInstruments2017-03-31SC209236ns5:ShareCapital2018-03-31SC209236ns5:ShareCapital2017-03-31SC209236ns5:RetainedEarningsAccumulatedLosses2018-03-31SC209236ns5:RetainedEarningsAccumulatedLosses2017-03-31SC209236ns5:FurnitureFittings2017-04-012018-03-31SC209236ns10:Director112017-03-31SC209236ns10:Director112016-03-31SC209236ns10:Director112017-04-012018-03-31SC209236ns10:Director112016-04-012017-03-31SC209236ns10:Director112018-03-31SC209236ns10:Director112017-03-31


REGISTERED NUMBER: SC209236 (Scotland)


















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2018

FOR

NEUROLOGY PARTNERSHIP LIMITED

NEUROLOGY PARTNERSHIP LIMITED (REGISTERED NUMBER: SC209236)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 31 March 2018




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 3


NEUROLOGY PARTNERSHIP LIMITED

COMPANY INFORMATION
for the Year Ended 31 March 2018







DIRECTORS: Dr R Swingler
Dr K El Bouzidi





REGISTERED OFFICE: 3 Coates Place
Edinburgh
EH3 7AA





REGISTERED NUMBER: SC209236 (Scotland)





ACCOUNTANTS: James Fraser & Co.
Chartered Accountants
3 Coates Place
Edinburgh
EH3 7AA

NEUROLOGY PARTNERSHIP LIMITED (REGISTERED NUMBER: SC209236)

ABRIDGED BALANCE SHEET
31 March 2018

2018 2017
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 5,573 4,898

CURRENT ASSETS
Debtors 16,255 13,133
Cash at bank 85,922 152,663
102,177 165,796
CREDITORS
Amounts falling due within one year 1,399 21,813
NET CURRENT ASSETS 100,778 143,983
TOTAL ASSETS LESS CURRENT
LIABILITIES

106,351

148,881

CAPITAL AND RESERVES
Called up share capital 140 140
Retained earnings 106,211 148,741
SHAREHOLDERS' FUNDS 106,351 148,881

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2018.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2018 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 31 March 2018 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors on 20 December 2018 and were signed on its behalf
by:




Dr R Swingler - Director


NEUROLOGY PARTNERSHIP LIMITED (REGISTERED NUMBER: SC209236)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 31 March 2018

1. STATUTORY INFORMATION

Neurology Partnership Limited is a private company, limited by shares , registered in Scotland. The company's
registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates,
value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to
the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or
substantively enacted by the balance sheet date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2017 - 2 ) .

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 April 2017 15,800
Additions 2,533
At 31 March 2018 18,333
DEPRECIATION
At 1 April 2017 10,902
Charge for year 1,858
At 31 March 2018 12,760
NET BOOK VALUE
At 31 March 2018 5,573
At 31 March 2017 4,898

NEUROLOGY PARTNERSHIP LIMITED (REGISTERED NUMBER: SC209236)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 March 2018

5. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2018 and
31 March 2017:

2018 2017
£    £   
Dr R Swingler
Balance outstanding at start of year 8,488 -
Amounts advanced 11,704 8,488
Amounts repaid (8,488 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 11,704 8,488